AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Sanziana Georgescu
Economy
sursa foto: unsplash.com
Always see our news on Google
British pharmaceutical company AstraZeneca, with a market capitalization of £161.2 billion, is considering a move to the US stock exchange because of dissatisfaction with UK regulations. The decision could reflect a wider trend in which companies prefer US markets for higher valuations and a bigger investor base. Experts believe AstraZeneca's departure would be a significant loss for the London Stock Exchange, which risks losing its status as a global financial center.
Sources
Latest News
09:06
A tanker was hit by an "unknown projectile" in the Strait of Hormuz, according to UKMTO.
08:44
Gabriela Ruse advances to round 2 at the WTA 1,000 in Toronto, after the victory against Peyton Stearns
08:31
25 U.S. states challenge the new import tariffs imposed by Donald Trump
08:05
Poland contests the ruling of the Brussels Tribunal to pay 1.3 billion euros for the Pfizer vaccines
07:45
Irineu Darău: "No matter how easy or populist it may be to promise some prices or even to limit them, great care must be taken / You cannot guarantee a price, but you can end up with shortages."
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
